Episode Mentions
BioSpace · May 13, 2026
Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay
“CEO Reshma Kowal-Rahmani dropped in compensation rankings after swapping places with GSK's Walmsley”
FDA Commissioner leadership transition and removalRegulatory uncertainty and HHS agency turnoverCommissioner's National Priority Review voucher program
View Analysis
Biotech Hangout · May 8, 2026
Episode 182 - May 8, 2026
“Large-cap biotech with pipeline events driving investor interest over commercial business strength”
Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns
View Analysis
Pharma and BioTech Daily · May 6, 2026
Sanofi Invests $294M in AI, FDA Approves Auvelity | Pharma and Biotech Daily
“Encountered tolerability issues with inhaled cystic fibrosis candidate developed with Moderna”
AI Center of Excellence and Digital Transformation in Drug DevelopmentFDA Approval Processes and Regulatory ModernizationCAR-T Cell Therapy Expansion Beyond Oncology
View Analysis
Founder's Story · Feb 27, 2026
The French Industrialist Betting on Robotics to Cure Disease (And the Ethical Line He Won’t Cross) | Ep. 316 with Hervé de Malliard President of Maison MGA
“Advanced R&D company in cell therapy that partnered with TreeFrog Therapeutics for cell encapsulation technology development”
Tech Bio Definition and ApplicationsPersonalized Medicine and Single-Vial-Per-Patient TherapiesCell and Gene Therapy Manufacturing
View Analysis